Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …
COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara… - Clinical …, 2020 - Elsevier
The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions. As
protective immunity does not exist in humans and the virus is capable of escaping innate …
protective immunity does not exist in humans and the virus is capable of escaping innate …
COVID-19: Immunology and treatment options
J Herbert - Clinical Immunology, 2020 - research.manchester.ac.uk
The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions. As
protective immunity does not exist in humans and the virus is capable of escaping innate …
protective immunity does not exist in humans and the virus is capable of escaping innate …
Pathogenesis guided therapeutic management of COVID-19: an immunological perspective
Lack of standardized therapeutic approaches is arguably the significant contributor to the
high burden of mortality observed in the ongoing pandemic of the Coronavirus disease …
high burden of mortality observed in the ongoing pandemic of the Coronavirus disease …
[HTML][HTML] COVID-19 Immunity Remains Complicated. And More Science Journal News| The Tyee
B Owens - Clinical Therapeutics, 2020 - thetyee.ca
COVID19TestTubeGlove. jpg How our immune system reacts to COVID-19, and how long
immunity might last, are important factors for understanding how long the pandemic might …
immunity might last, are important factors for understanding how long the pandemic might …
[HTML][HTML] A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
Y Mohamed, YA El-Maradny, AK Saleh… - Biomedicine & …, 2022 - Elsevier
The healthy immune system eliminates pathogens and maintains tissue homeostasis
through extraordinarily complex networks with feedback systems while avoiding potentially …
through extraordinarily complex networks with feedback systems while avoiding potentially …
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and …
A Saghazadeh, N Rezaei - International immunopharmacology, 2020 - Elsevier
The novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in
humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma …
humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma …
The possible of immunotherapy for COVID-19: A systematic review
A AminJafari, S Ghasemi - International immunopharmacology, 2020 - Elsevier
Abstract The novel coronavirus (2019-nCoV) is an emerging pathogen that was first
described in late December 2019 and causes a severe respiratory infection in humans …
described in late December 2019 and causes a severe respiratory infection in humans …
Prospects for a COVID-19 treatment
AA Starshinova, EA Kushnareva… - Translational …, 2020 - transmed.almazovcentre.ru
In the context of the new coronavirus infection spreading it is particularly relevance to obtain
information on the clinical course, diagnostic possibilities and features of the COVID-19 …
information on the clinical course, diagnostic possibilities and features of the COVID-19 …
The immunology and immunotherapy for COVID-19
Y Liu, X Zhou, X Liu, X Jiang - Expert reviews in molecular medicine, 2021 - cambridge.org
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) is caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and significantly impacts the world …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and significantly impacts the world …